AHA drills into CV risk factors in children

A weight-loss drug is poised for expanded indication, the FDA says a popular gout drug raises cardiovascular risk, an AHA statement targets CV risk factors in children, and a class action suit against the American Board of Internal Medicine over MOC gets financial support from doctors.

Amazon AlexaApple Podcasts

Google Podcasts

TuneIn

A weight-loss drug is poised for expanded indication, the FDA says a popular gout drug raises cardiovascular risk, an AHA statement targets CV risk factors in children, and a class action suit against the American Board of Internal Medicine over MOC gets financial support from doctors.

Amazon AlexaApple Podcasts

Google Podcasts

TuneIn

A weight-loss drug is poised for expanded indication, the FDA says a popular gout drug raises cardiovascular risk, an AHA statement targets CV risk factors in children, and a class action suit against the American Board of Internal Medicine over MOC gets financial support from doctors.

Amazon AlexaApple Podcasts

Google Podcasts

TuneIn